Common Contracts
7 similar Supply and Commercialization Agreement contracts
June 2015—Horizon Discovery Group has signed a supply and commercialization agreement with Thermo Fisher Scientific. Under the terms of the agreement, Thermo Fisher will market and distribute Horizon’s X-MAN human haploid and diploid isogenic cell...Supply and Commercialization Agreement • September 26th, 2022
The X-MAN cell line range represents an extensive bank of genetically defined human cell lines—models that accurately exhibit disease-causing genetics and have undergone a high degree of validation and quality control. These models help researchers to understand how complex genetic diseases manifest themselves, and can reduce the cost of bringing to market new personalized therapies by streamlining many aspects of drug development, including target identification, target validation, assay development, drug screening, lead optimization, and biomarker-driven clinical trial design.
June 2015—Horizon Discovery Group has signed a supply and commercialization agreement with Thermo Fisher Scientific. Under the terms of the agreement, Thermo Fisher will market and distribute Horizon’s X-MAN human haploid and diploid isogenic cell...Supply and Commercialization Agreement • June 11th, 2021
The X-MAN cell line range represents an extensive bank of genetically defined human cell lines—models that accurately exhibit disease-causing genetics and have undergone a high degree of validation and quality control. These models help researchers to understand how complex genetic diseases manifest themselves, and can reduce the cost of bringing to market new personalized therapies by streamlining many aspects of drug development, including target identification, target validation, assay development, drug screening, lead optimization, and biomarker-driven clinical trial design.
June 2015—Horizon Discovery Group has signed a supply and commercialization agreement with Thermo Fisher Scientific. Under the terms of the agreement, Thermo Fisher will market and distribute Horizon’s X-MAN human haploid and diploid isogenic cell...Supply and Commercialization Agreement • June 11th, 2021
The X-MAN cell line range represents an extensive bank of genetically defined human cell lines—models that accurately exhibit disease-causing genetics and have undergone a high degree of validation and quality control. These models help researchers to understand how complex genetic diseases manifest themselves, and can reduce the cost of bringing to market new personalized therapies by streamlining many aspects of drug development, including target identification, target validation, assay development, drug screening, lead optimization, and biomarker-driven clinical trial design.
June 2015—Horizon Discovery Group has signed a supply and commercialization agreement with Thermo Fisher Scientific. Under the terms of the agreement, Thermo Fisher will market and distribute Horizon’s X-MAN human haploid and diploid isogenic cell...Supply and Commercialization Agreement • June 11th, 2021
The X-MAN cell line range represents an extensive bank of genetically defined human cell lines—models that accurately exhibit disease-causing genetics and have undergone a high degree of validation and quality control. These models help researchers to understand how complex genetic diseases manifest themselves, and can reduce the cost of bringing to market new personalized therapies by streamlining many aspects of drug development, including target identification, target validation, assay development, drug screening, lead optimization, and biomarker-driven clinical trial design.
June 2015—Horizon Discovery Group has signed a supply and commercialization agreement with Thermo Fisher Scientific. Under the terms of the agreement, Thermo Fisher will market and distribute Horizon’s X-MAN human haploid and diploid isogenic cell...Supply and Commercialization Agreement • June 11th, 2021
The X-MAN cell line range represents an extensive bank of genetically defined human cell lines—models that accurately exhibit disease-causing genetics and have undergone a high degree of validation and quality control. These models help researchers to understand how complex genetic diseases manifest themselves, and can reduce the cost of bringing to market new personalized therapies by streamlining many aspects of drug development, including target identification, target validation, assay development, drug screening, lead optimization, and biomarker-driven clinical trial design.
June 2015—Horizon Discovery Group has signed a supply and commercialization agreement with Thermo Fisher Scientific. Under the terms of the agreement, Thermo Fisher will market and distribute Horizon’s X-MAN human haploid and diploid isogenic cell...Supply and Commercialization Agreement • June 11th, 2021
The X-MAN cell line range represents an extensive bank of genetically defined human cell lines—models that accurately exhibit disease-causing genetics and have undergone a high degree of validation and quality control. These models help researchers to understand how complex genetic diseases manifest themselves, and can reduce the cost of bringing to market new personalized therapies by streamlining many aspects of drug development, including target identification, target validation, assay development, drug screening, lead optimization, and biomarker-driven clinical trial design.
June 2015—Horizon Discovery Group has signed a supply and commercialization agreement with Thermo Fisher Scientific. Under the terms of the agreement, Thermo Fisher will market and distribute Horizon’s X-MAN human haploid and diploid isogenic cell...Supply and Commercialization Agreement • June 11th, 2021
The X-MAN cell line range represents an extensive bank of genetically defined human cell lines—models that accurately exhibit disease-causing genetics and have undergone a high degree of validation and quality control. These models help researchers to understand how complex genetic diseases manifest themselves, and can reduce the cost of bringing to market new personalized therapies by streamlining many aspects of drug development, including target identification, target validation, assay development, drug screening, lead optimization, and biomarker-driven clinical trial design.
